Autonomix Medical (AMIX) Net Equity Issued and Repurchased (2023 - 2025)

Autonomix Medical (AMIX) has reported Net Equity Issued and Repurchased for 3 consecutive years, with $1.3 million the latest figure, recorded in Q4 2025.

• On a quarterly basis, Net Equity Issued and Repurchased changed N/A year-over-year to $1.3 million in Q4 2025; TTM through Dec 2025 was $3.4 million, a 19.79% increase from a year earlier, with the FY2024 full-year figure at $2.8 million, up 320.74% from the prior year.
• Net Equity Issued and Repurchased was $1.3 million for Q4 2025 at Autonomix Medical, up from -$21000.0 in the prior quarter.
• Over five years, Net Equity Issued and Repurchased peaked at $2.8 million in Q2 2023 and troughed at -$21000.0 in Q3 2025.
• A 3-year average of $1.4 million and a median of $1.3 million in 2025 frame the typical range for Net Equity Issued and Repurchased.
• Across the five-year window, Net Equity Issued and Repurchased jumped 320.74% in 2024 and tumbled 99.93% in 2025, its largest moves.
• Over 3 years, Net Equity Issued and Repurchased stood at $2.8 million in 2023, then changed by 0.0% to $2.8 million in 2024, then tumbled by 54.23% to $1.3 million in 2025.
• The last three Net Equity Issued and Repurchased figures came in at $1.3 million (Q4 2025), -$21000.0 (Q3 2025), and $2.1 million (Q2 2025), per Business Quant data.